Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate CAR-T reimbursements. Advocated for advanced cancer care access.
Duration: July 1, 2006
to
August 22, 2019
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations , Aerospace , Medical/Disease Research/Clinical Labs
Spending: about $1,375,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2006: U.S. Senate, House of Representatives, White House Office, Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
3rd Quarter, 2019
The Petrizzo Group, Inc. terminated an engagement in which they represented Seattle Cancer Care Alliance on Aug. 23, 2019.
Original Filing: 301061428.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate CAR-T reimbursements. Advocated for advanced cancer care access.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate CAR-T reimbursements. Advocated for advanced cancer care access.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $50,000. The report was filed on July 18, 2019.
Original Filing: 301048903.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate CAR-T reimbursements. Advocated for advanced cancer care access.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate CAR-T reimbursements. Advocated for advanced cancer care access.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2019
In Q1, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $50,000. The report was filed on April 15, 2019.
Original Filing: 301025684.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate CAR-T reimbursements. Advocated for advanced cancer care access.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate CAR-T reimbursements. Advocated for advanced cancer care access.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $50,000. The report was filed on Jan. 14, 2019.
Original Filing: 301004076.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for CAR-T reimbursement.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate reimbursement for immunotherapy CAR-T treatments.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate reimbursement for immunotherapy CAR-T treatments.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $50,000. The report was filed on Oct. 14, 2018.
Original Filing: 300985049.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated for current law treatment of dedicated cancer centers under Medicare off-campus outpatient hospital reimbursement.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated for current law treatment of dedicated cancer centers under Medicare off-campus outpatient hospital reimbursement. Government payment system for immunotherapy CAR-T.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2018
In Q2, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $45,000. The report was filed on July 17, 2018.
Original Filing: 300965850.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated for current law treatment of dedicated cancer centers under Medicare off-campus outpatient hospital reimbursement.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated for current law treatment of dedicated cancer centers under Medicare off-campus outpatient hospital reimbursement. Government payment system for immunotherapy CAR-T.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2018
In Q1, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $60,000. The report was filed on April 15, 2018.
Original Filing: 300944777.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated for current law treatment of dedicated cancer centers under Medicare off-campus outpatient hospital reimbursement.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated for current law treatment of dedicated cancer centers under Medicare off-campus outpatient hospital reimbursement.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2017
In Q4, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $50,000. The report was filed on Jan. 16, 2018.
Original Filing: 300924292.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated to maintain current law pre-existing conditions protections and annual-lifetime spending caps for all cancer patients.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated to maintain current law pre-existing conditions protections and annual-lifetime spending caps for all cancer patients.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2017
In Q3, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $50,000. The report was filed on Oct. 16, 2017.
Original Filing: 300904139.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated to maintain current law pre-existing conditions protections and annual-lifetime spending caps for all cancer patients.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated to maintain current law pre-existing conditions protections and annual-lifetime spending caps for all cancer patients.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
In Q2, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $50,000. The report was filed on July 13, 2017.
Original Filing: 300884174.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated to maintain current law pre-existing conditions protections and annual-lifetime spending caps for all cancer patients.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated to maintain current law pre-existing conditions protections and annual-lifetime spending caps for all cancer patients.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2017
In Q1, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $50,000. The report was filed on April 10, 2017.
Original Filing: 300863713.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated to maintain current law pre-existing conditions protections and annual-lifetime spending caps for all cancer patients.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for QHPs. Advocated to maintain current law pre-existing conditions protections and annual-lifetime spending caps for all cancer patients.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2016
In Q4, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on Jan. 14, 2017.
Original Filing: 300846333.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Opposed Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care. Advocated for provisions included in H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Opposed Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care. Advocated for provisions included in H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2016
In Q3, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on Oct. 14, 2016.
Original Filing: 300828060.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Opposed Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care. Advocated for H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016. Advocated for improvements to FDA approval process.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Opposed Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care. Advocated for H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Opposed Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care. Advocated for H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on July 11, 2016.
Original Filing: 300808168.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Opposed Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care. Advocated for H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Opposed Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care. Advocated for H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2016
In Q1, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on April 19, 2016.
Original Filing: 300794345.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Opposed Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Opposed Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2015
In Q4, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on Jan. 15, 2016.
Original Filing: 300773364.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Advocated for H.R. 1220 / S. 624, the Removing Barriers to Colorectal Cancer Screening Act. Advocated for H.R. 3119, the Palliative Care and Hospice Education and Training Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Advocated for H.R. 1220 / S. 624, the Removing Barriers to Colorectal Cancer Screening Act. Advocated for H.R. 3119, the Palliative Care and Hospice Education and Training Act. Oppose Section 603 of the Bipartisan Budget Act of 2015 to reduce payments to dedicated cancer centers for outpatient care.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2015
In Q3, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on Oct. 19, 2015.
Original Filing: 300756627.xml
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Advocated against H.R. 2895 and against reducing hospital outpatient cancer payments.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for network adequacy requirements for Qualified Health Plans. Advocated against H.R. 2895 and against reducing hospital outpatient cancer payments.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2015
In Q2, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on July 19, 2015.
Original Filing: 300740016.xml
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under arrangement.
Advocated against proposed changes to the evaluation and management(E/M) services.
Advocated on behalf of current law designation and payment for dedicated cancer centers.
Network Adequacy Requirements for QHPs.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under arrangement.
Advocated against proposed changes to the evaluation and management(E/M) services.
Advocated on behalf of current law designation and payment for dedicated cancer centers.
Network Adequacy Requirements for QHPs.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2015
In Q1, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on April 14, 2015.
Original Filing: 300714852.xml
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under arrangement.
Advocated against proposed changes to the evaluation and management(E/M) services.
Advocated on behalf of current law designation and payment for dedicated cancer centers.
Network Adequacy Requirements for QHPs.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under arrangement.
Advocated against proposed changes to the evaluation and management(E/M) services.
Advocated on behalf of current law designation and payment for dedicated cancer centers.
Network Adequacy Requirements for QHPs.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2014
In Q4, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on Jan. 21, 2015.
Original Filing: 300708396.xml
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under arrangement.
Advocated against proposed changes to the evaluation and management (e/M) services.
Advocated on behalf of current law designation for dedicated cancer center.
Network Adequacy Requirements for QHPs.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under arrangement.
Advocated against proposed changes to the evaluation and management (e/M) services.
Advocated on behalf of current law designation for dedicated cancer center.
Network Adequacy Requirements for QHPs.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance . The report was filed on Oct. 18, 2014.
Original Filing: 300682061.xml
Lobbying Issues
The Suborbital and Orbital Advancement and Regulatory Streamlining (SOARS) Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on July 14, 2014.
Original Filing: 300656061.xml
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under agreement provisions.
Advocated against proposed changes to the evaluation and management (E/M) services as between HOPDs and physician offices.
Advocated on behalf of current law designation for dedicated cancer centers.
Network Adequacy Requirements for QHPs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under agreement provisions.
Advocated against proposed changes to the evaluation and management (E/M) services as between HOPDs and physician offices.
Advocated on behalf of current law designation for dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Appropriations
1st Quarter, 2014
In Q1, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on April 19, 2014.
Original Filing: 300642807.xml
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under agreement provisions.
Advocated against proposed changes to the evaluation and management (E/M) services as between HOPDs and physician offices.
Advocated on behalf of current law designation for dedicated cancer centers.
Network Adequacy Requirements for QHPs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under agreement provisions.
Advocated against proposed changes to the evaluation and management (E/M) services as between HOPDs and physician offices.
Advocated on behalf of current law designation for dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Appropriations
4th Quarter, 2013
In Q4, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on Jan. 7, 2014.
Original Filing: 300611833.xml
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under agreement provisions.
Advocated against proposed changes to the evaluation and management (E/M) services as between HOPDs and physician offices.
Advocated on behalf of current law designation for dedicated cancer centers.
Network Adequacy Requirements for QHPs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under agreement provisions.
Advocated against proposed changes to the evaluation and management (E/M) services as between HOPDs and physician offices.
Advocated on behalf of current law designation for dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Appropriations
3rd Quarter, 2013
In Q3, The Petrizzo Group, Inc. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on Oct. 6, 2013.
Original Filing: 300590909.xml
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under agreement provisions.
Advocated against proposed changes to the evaluation and management (E/M) services as between HOPDs and physician offices.
Advocated on behalf of current law designation for dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid/Appropriations
2nd Quarter, 2013
In Q2, PETRIZZO BOND, INC. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on July 18, 2013.
Original Filing: 300574941.xml
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under agreement provisions.
Advocated against proposed changes to the evaluation and management (E/M) services as between HOPDs and physician offices.
Advocated on behalf of current law designation for dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid/Appropriations
1st Quarter, 2013
In Q1, PETRIZZO BOND, INC. lobbied for Seattle Cancer Care Alliance , earning $30,000. The report was filed on April 20, 2013.
Original Filing: 300557949.xml
Lobbying Issues
Advocated for modifications to the CMS new interpretation of services under agreement provisions.
Advocated against proposed changes to the evaluation and management (E/M) services as between HOPDs and physician offices.
Advocated on behalf of current law designation for dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid/Appropriations
4th Quarter, 2012
In Q4, PETRIZZO BOND, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Jan. 21, 2013.
Original Filing: 300537564.xml
Lobbying Issues
Concerned with the impact potential Medicare cuts and sequestration could have on SCCA.
Opposed CMS' new interpretation of services under agreement provision in recent IPPS rulemakings due to a number of patient safety concerns
Opposed the proposed evaluation in management services payment reduction
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid/Appropriations
3rd Quarter, 2012
In Q3, PETRIZZO BOND, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Oct. 17, 2012.
Original Filing: 300509300.xml
Lobbying Issues
Concerned with the impact potential Medicare cuts and sequestration could have on SCCA.
Concerned with the proposed IPPS Rule.
Concerned with pending quality measures and Reporting Rule, and a services under agreement issue pending with the Administration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Concerned with the impact potential Medicare cuts and sequestration could have on SCCA.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Appropriations
2nd Quarter, 2012
PETRIZZO BOND, INC. amended a lobbying report for representation of Seattle Cancer Care Alliance in Q22012 on Oct. 1, 2012.
Original Filing: 300503487.xml
Lobbying Issues
Concerned with the impact of potential Medicare cuts and sequestration could have on SCCA
Concerned with the proposed IPPS Rule.
Concerns with pending quality measures and Reporting Rule, and a services under agreement issue pending with the Administration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Concerned with the impact of potential Medicare cuts and sequestration could have on SCCA.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Appropriations
2nd Quarter, 2012
In Q2, PETRIZZO BOND, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on July 16, 2012.
Original Filing: 300484591.xml
Lobbying Issues
Concerned with the impact of potential Medicare cuts and sequestration could have on SCCA.
Concerned with the proposed IPPS Rule.
Concerns with pending quality measures and Reporting Rule, and
a services under agreement issue pending with the Administration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Concerned with the impact of potential Medicare cuts and sequestration could have on SCCA.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid/Appropriations
1st Quarter, 2012
In Q1, PETRIZZO BOND, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on April 16, 2012.
Original Filing: 300460954.xml
Lobbying Issues
Advocated for CMS action that would account for SCCA outpatient concentration, or in the alternative, ensure that SCCA loses per unit of PPS hospitals.Advocated that CMS ensure cancer patients have access to all NCI designated comprehensive cancer centers, including dedicated cancer centers like SCCA, as it develops ACO payment models. Concerns with CMS review of SCCA cost reports.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, PETRIZZO BOND, INC. (PETRIZZO STRATEGIC GROUP, INC.) lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Jan. 10, 2012.
Original Filing: 300435647.xml
Lobbying Issues
Advocated for CMS action that would account for SCCA outpatient concentration, or in the alternative, ensure that SCCA losses per unit of PPS hospitals. Advocated that CMS ensure cancer patients have access to all NCI designated comprehensive cancer centers, including dedicated cancer centers like SCCA, as it develops ACO payment models.
Concerns with CMS review of SCCA cost reports.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Oct. 12, 2011.
Original Filing: 300412672.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and the National Cancer Institute
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated for CMS action that would account for SCCA outpatient concentration, or in the alternative, ensure that SCCA losses per unit of PPS hospitals. Avocated that CMS ensure cancer patients have access to all NCI designated comprehensive cancer centers, including dedicated cancer centers like SCCA, as it develops ACO payment models. Concerns with CMS review of SCCA cost reports.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2011
In Q2, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on July 16, 2011.
Original Filing: 300391778.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and the National Cancer Institute.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated for exemption of dedicated cancer centers from Value Based Purchasing provisions of ACA. Advocated for CMS action that would account for SCCA outpatient concentration, or in the alternative, ensure that SCCA losses per unit equals the losses per unit of PPS hospitals. Advocated that CMS ensure cancer patients have access to all NCI designated comprehensive cancer centers, including dedicated cancer centers like SCCA, as it develops ACO payment models. Concerns w/CMS review of SCCA cost reports.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2011
In Q1, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on April 18, 2011.
Original Filing: 300366039.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and the National Cancer Institute. Advocated for funding from Department of Energy for proton beam therapy center.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocated for exemption of dedicated cancer centers from Value Based Purchasing provisions of ACA. Advocated for CMS action that would account for SCCA outpatient concentration, or in the alternative, ensure that SCCA losses per unit equals the losses per unit of PPS hospitals. Advocated that CMS ensure cancer patients have access to all NCI designated comprehensive cancer centers, including dedicated cancer centers like SCCA, as it develops ACO payment models. Concerns w/CMS review of SCCA cost reports.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.
Support introduction and passage of The Cancer Center Assistance for Renovation and Expansion Act, H.R. 5861.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2010
In Q4, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Jan. 17, 2011.
Original Filing: 300339249.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and the National Cancer Institute to be increased to a sustainable level that recognizes the impact of biomedical inflation, puts us back on a path to reap the benefits of the doubling of the NIH budget and allows cancer institutions to continue to make important progress in the war against cancer.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for outpatient payment update under the Outpatient Prospective Payment System for dedicated cancer centers. Support enactment of Improving Access to Clinical Trials Act of 2010 -- S.1674.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.
Support introduction and passage of The Cancer Center Assistance for Renovation and Expansion Act, H.R. 5861.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2010
In Q3, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Oct. 16, 2010.
Original Filing: 300314570.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and the National Cancer Institute to be increased to a sustainable level that recognizes the impact of biomedical inflation, puts us back on a path to reap the benefits of the doubling of the NIH budget and allows cancer institutions to continue to make important progress in the war against cancer.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for 3 year temporary outpatient relief under the Outpatient Prospective Payment System for dedicated cancer centers, while MedPAC examines outpatient shortfalls in greater detail.
Providing Access to Clinical Trials:
Clinical trials are one of the most important keys to advancing cancer treatment. Advocated for federal legislation to requirei nsurers to: (1) not be able to deny individuals from participating in all phases of cancer clinical trials; and, (2) cover the routine patient care costs for items and services furnished in connection with trials.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2010
In Q2, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on July 18, 2010.
Original Filing: 300290765.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and the National Cancer Institute to be increased to a sustainable level that recognizes the impact of biomedical inflation, puts us back on a path to reap the benefits of the doubling of the NIH budget and allows cancer institutions to continue to make important progress in the war against cancer.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for 3 year temporary outpatient relief under the Outpatient Prospective Payment System for dedicated cancer centers, while MedPAC examines outpatient shortfalls in greater detail.
Providing Access to Clinical Trials:
Clinical trials are one of the most important keys to advancing cancer treatment. Advocated for federal legislation to requirei nsurers to: (1) not be able to deny individuals from participating in all phases of cancer clinical trials; and, (2) cover the routine patient care costs for items and services furnished in connection with trials.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2010
In Q1, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on April 18, 2010.
Original Filing: 300262175.xml
Lobbying Issues
Advocated for funding for the National Institutes of Health and the National Cancer Institute to be increased to a sustainable level that recognizes the impact of biomedical inflation, puts us back on a path to reap the benefits of the doubling of the NIH budget and allows cancer institutions to continue to make important progress in the war against cancer.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for 3 year temporary outpatient relief under the Outpatient Prospective Payment System for dedicated cancer centers, while MedPAC examines outpatient shortfalls in greater detail.
Providing Access to Clinical Trials:
Clinical trials are one of the most important keys to advancing cancer treatment. Advocated for federal legislation to requirei nsurers to: (1) not be able to deny individuals from participating in all phases of cancer clinical trials; and, (2) cover the routine patient care costs for items and services furnished in connection with trials.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2009
In Q4, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Jan. 14, 2010.
Original Filing: 300230980.xml
Lobbying Issues
Advocate for federal funding for Proton Beam Therapy Center. Advance support for Cancer Center Infrastructure Improvement Program. Advocate for updated payments for Outpatient Prospective Payment System for dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
3rd Quarter, 2009
In Q3, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Oct. 19, 2009.
Original Filing: 300209211.xml
Lobbying Issues
Advocate for federal funding for Proton Beam Therapy Center. Advance support for Cancer Center Infrastructure Improvement Program. Advocate for updated payments for Outpatient Prospective Payment System for dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
2nd Quarter, 2009
In Q2, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on July 19, 2009.
Original Filing: 300185806.xml
Lobbying Issues
Secure federal funding for Proton Beam Therapy Center. Advance support for Cancer Center Infrastructure Improvement Program.
Advance update in payments for Outpatient Prospective Payment System for dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
1st Quarter, 2009
In Q1, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on April 19, 2009.
Original Filing: 300155910.xml
Lobbying Issues
Secure federal funding for Proton Beam Therapy Center. Advance support Cancer Center Indrastructure Improvement Program.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
4th Quarter, 2008
In Q4, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Jan. 20, 2009.
Original Filing: 300127613.xml
Lobbying Issues
Secure federal funding for the Proton Beam Therapy Center. Support reauthorization of TEFRA and provisions related to the reimbursement of dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
3rd Quarter, 2008
In Q3, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $20,000. The report was filed on Oct. 18, 2008.
Original Filing: 300100142.xml
Lobbying Issues
Secure funding for the Proton Beam Therapy Center. Support reauthorization of TEFRA and provisions related to reimbursement of dedicated cancer centers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
2nd Quarter, 2008
PETRIZZO STRATEGIC GROUP, INC. amended a lobbying report for representation of Seattle Cancer Care Alliance in Q22008 on Nov. 2, 2008.
Original Filing: 300110977.xml
Lobbying Issues
Secure funding for the Proton Beam Therapy Center. Support reauthorization of TEFRA and provisions related to dedicated cancer centers re-basing.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
2nd Quarter, 2008
In Q2, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $10,000. The report was filed on July 15, 2008.
Original Filing: 300065615.xml
Lobbying Issues
Secure funding for Proton Beam Therapy Center. Support reauthorization of TEFRA and provisions related to dedicated cancer centers re-basing.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
1st Quarter, 2008
In Q1, PETRIZZO STRATEGIC GROUP, INC. lobbied for Seattle Cancer Care Alliance , earning $10,000. The report was filed on April 18, 2008.
Original Filing: 300045980.xml
Lobbying Issues
Secure federal fudning for Proton Beam Therapy Center
Support reauthorization of TEFRA and provisions realted to dedicated cancer centers re-basing
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations/Disease Research/Clinical Labs
3rd Quarter, 2006
Petrizzo Strategic Group, Inc. filed a lobbying registration on July 26, 2006 to represent Seattle Cancer Care Alliance, effective July 1, 2006.
Original Filing: 100028250.xml
Issue(s) they said they’d lobby about: Federal Appropriations for Mobile Mammography United for underserved areas of the Pacific Northwest
Increased funding for NIH/NCI .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...